ТHE ROLE OF GENETIC TESTING FOR OPTIMAL ANTIPLATELET THERAPY SELECTION IN THE TREATMENT OF CORONARY ARTERY DISEASE PATIENTS

ТHE ROLE OF GENETIC TESTING FOR OPTIMAL ANTIPLATELET THERAPY SELECTION IN THE TREATMENT OF CORONARY ARTERY DISEASE PATIENTS

The studies of coronary heart disease as a cause of reduced life quality and disability in population led to improved methods of diagnosis and treatment of this disease. To date, accumulated large evidence base supports the use of DAT (dual antiplatelet therapy) in patients with coronary artery dise...

Full description

Bibliographic Details
Main Authors:	S. T. Matskeplishvili, Y. E. Arutyunova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2014-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary artery disease dual antiplatelet therapy genetic testing
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/46

Similar Items

Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)

CONTEMPORARY APPROACHES TO ANTIPLATELET THERAPY IN CORONARY HEART DISEASE TREATMENT
by: S. T. Matskeplishvili, et al.
Published: (2014-08-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
by: Hua Yan, et al.
Published: (2020-06-01)

Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]
by: Gasparovic Hrvoje, et al.
Published: (2012-08-01)

Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
by: Alessandro Caracciolo, et al.
Published: (2019-11-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
by: Paolo Nardi, et al.
Published: (2021-10-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis
by: Xiaojun Zhuo, et al.
Published: (2018-09-01)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
by: Ying Shen, et al.
Published: (2015-01-01)

Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma
by: Surya Chaturvedula, et al.
Published: (2018-04-01)

Antiplatelet therapy in elderly patients with acute coronary syndrome: Between scientific evidence and future perspectives
by: Francesco Barillà, et al.
Published: (2018-06-01)

Duration of antiplatelet therapy cessation before coronary artery bypass surgery: Relation with platelet count
by: Sushil Prakash Ambesh
Published: (2015-07-01)

Review of Antiplatelet Therapy for the Management of Acute Coronary Syndromes
by: Ganesh Nallur Shivu
Published: (2016-10-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
by: Fan ZG, et al.
Published: (2016-10-01)

Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Goto, Koji
Published: (2015)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

Effect of acute coronary syndrome patients’ education on adherence to dual antiplatelet therapy
by: Hassan El-Toukhy, et al.
Published: (2017-10-01)

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?
by: Yu. I. Grinschtein, et al.
Published: (2014-06-01)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
by: Gregorio Tersalvi, et al.
Published: (2020-07-01)

Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies
by: Yoshikawa, Yusuke
Published: (2020)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
by: Feng Huang
Published: (2018-06-01)

Dual antiplatelet therapy in ischemic stroke
by: Birsen İnce
Published: (2019-08-01)

Outcomes with Longterm Dual Antiplatelet Therapy After Coronary Angioplasty
by: Ashok Kumar Arigonda, et al.
Published: (2016-09-01)

Antithrombotic treatments for patients with atrial fibrillation and a requirement for a coronary artery stent
by: Andrew.Owen
Published: (2013-01-01)

Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials
by: Yijiang Zhou, et al.
Published: (2017-06-01)

Update of Antiplatelet Therapy in Patients Without Known Cardiovascular Disease
by: Tomasevic Miloje, et al.
Published: (2018-12-01)

Duration of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Treated With New Generation Stents: A Meta-Analysis of Randomized Controlled Trials
by: Wen-Jiao Zhang, et al.
Published: (2021-02-01)

Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xi-Ying Liang, et al.
Published: (2021-07-01)

Prescription Rates for Antiplatelet Therapy (APT) in Coronary Artery Disease (CAD) – What Benchmark are We Aiming at in Continuing Medical Education (CME)?
by: Bernd Hagen, et al.
Published: (2020-01-01)

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia
by: Francisco José Fernández-Fernández, et al.
Published: (2017-10-01)

P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Sohyun Park, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_sr9knb1uf35epgqd010nr08m01